Screener
Charles River Laboratories CRL Accounts Receivable
Accounts Receivable at other companies
Other financials
Where this comes from
Reported directly by Charles River Laboratories in its filing.
Tagged under the XBRL concept us-gaap:AccountsReceivableGrossCurrent.
The source filing: Charles River Laboratories’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 9:21 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001100682-26-000118
| Line item | June 27, 2026 | December 27, 2025 |
|---|---|---|
| Assets from contracts with customers | ||
| Client receivables | $524,810 | $518,728 |
| Unbilled revenue | 195,660 | 200,591 |
| Total | 720,470 | 719,319 |
| Less: Allowance for credit losses | (8,715) | (10,463) |
| Trade receivables and contract assets, net | $711,755 | $708,856 |
| Liabilities from contracts with customers | ||
| Current deferred revenue | $203,035 | $210,418 |
Item 1. Financial Statements
FAQ
- What is Charles River Laboratories's accounts receivable?
- Charles River Laboratories (CRL) reported accounts receivable of $720.47M in Q2 2026.
- How has Charles River Laboratories's accounts receivable changed year-over-year?
- Charles River Laboratories's accounts receivable decreased by 7.7% year-over-year, from $780.41M to $720.47M.
- What is the long-term trend for Charles River Laboratories's accounts receivable?
- Over 5 years (2020 to 2025), Charles River Laboratories's accounts receivable has grown at a 2.9% compound annual growth rate (CAGR), from $624.44M to $719.32M.
- What does accounts receivable mean?
- Amounts owed by customers for goods delivered or services performed, net of allowances for doubtful accounts. A key working capital component.
Ask your AI about Charles River Laboratories's accounts receivable.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude